Lawrence David Scahill

46.0k total citations · 5 hit papers
358 papers, 23.4k citations indexed

About

Lawrence David Scahill is a scholar working on Clinical Psychology, Cognitive Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Lawrence David Scahill has authored 358 papers receiving a total of 23.4k indexed citations (citations by other indexed papers that have themselves been cited), including 278 papers in Clinical Psychology, 210 papers in Cognitive Neuroscience and 161 papers in Psychiatry and Mental health. Recurrent topics in Lawrence David Scahill's work include Autism Spectrum Disorder Research (207 papers), Obsessive-Compulsive Spectrum Disorders (154 papers) and Child Nutrition and Feeding Issues (86 papers). Lawrence David Scahill is often cited by papers focused on Autism Spectrum Disorder Research (207 papers), Obsessive-Compulsive Spectrum Disorders (154 papers) and Child Nutrition and Feeding Issues (86 papers). Lawrence David Scahill collaborates with scholars based in United States, Canada and United Kingdom. Lawrence David Scahill's co-authors include James F. Leckman, Susan W. White, Robert A. King, Mark A. Riddle, Thomas H. Ollendick, Donald P. Oswald, Christopher J. McDougle, James T. McCracken, Sharon I. Ort and Michael G. Aman and has published in prestigious journals such as JAMA, American Journal of Psychiatry and Neurology.

In The Last Decade

Lawrence David Scahill

351 papers receiving 22.4k citations

Hit Papers

Children's Yale-Brown Obs... 1997 2026 2006 2016 1997 2009 2006 2013 2010 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Children's Yale-Brown Obsessive Compulsive Scale: Reliability and Validity
    1997 1.5k citations Lawrence David Scahill, Mark A. Riddle et al. profile →
  2. Anxiety in children and adolescents with autism spectrum disorders
    2009 1.0k citations Lawrence David Scahill et al. profile →
  3. Social Skills Development in Children with Autism Spectrum Disorders: A Review of the Intervention Research
    2006 584 citations Lawrence David Scahill et al. Journal of Autism and Developmental Disorders profile →
  4. The Role of Emotion Regulation in Autism Spectrum Disorder
    2013 555 citations Lawrence David Scahill et al. profile →
  5. Behavior Therapy for Children With Tourette Disorder
    2010 463 citations John Piacentini, Douglas W. Woods et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lawrence David Scahill United States 84 16.6k 14.6k 9.0k 2.7k 1.7k 358 23.4k
James T. McCracken United States 83 10.1k 0.6× 10.1k 0.7× 9.7k 1.1× 1.7k 0.6× 3.0k 1.7× 325 20.9k
Russell Schachar Canada 77 5.3k 0.3× 9.1k 0.6× 10.6k 1.2× 3.3k 1.3× 2.2k 1.3× 293 18.8k
Luís Augusto Rohde Brazil 59 8.7k 0.5× 8.4k 0.6× 15.9k 1.8× 3.2k 1.2× 2.5k 1.5× 465 24.4k
Joel T. Nigg United States 84 9.0k 0.5× 12.7k 0.9× 16.0k 1.8× 4.3k 1.6× 4.5k 2.6× 260 26.2k
Ellen Leibenluft United States 90 14.4k 0.9× 9.7k 0.7× 12.6k 1.4× 1.1k 0.4× 7.8k 4.5× 410 27.2k
Christopher J. McDougle United States 72 6.1k 0.4× 9.1k 0.6× 6.3k 0.7× 1.1k 0.4× 1.0k 0.6× 311 14.9k
Rosemary Tannock Canada 79 5.6k 0.3× 11.7k 0.8× 15.4k 1.7× 6.3k 2.4× 3.4k 2.0× 232 22.8k
Neal D. Ryan United States 81 17.7k 1.1× 7.0k 0.5× 12.3k 1.4× 916 0.3× 7.0k 4.1× 334 30.6k
Eric Mick United States 75 7.4k 0.4× 6.9k 0.5× 16.1k 1.8× 2.3k 0.9× 1.7k 1.0× 206 20.5k
C. Keith Conners United States 62 9.5k 0.6× 7.8k 0.5× 14.4k 1.6× 4.6k 1.7× 2.8k 1.6× 147 22.3k

Countries citing papers authored by Lawrence David Scahill

Since Specialization
Citations

This map shows the geographic impact of Lawrence David Scahill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence David Scahill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence David Scahill more than expected).

Fields of papers citing papers by Lawrence David Scahill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence David Scahill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence David Scahill. The network helps show where Lawrence David Scahill may publish in the future.

Co-authorship network of co-authors of Lawrence David Scahill

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence David Scahill. A scholar is included among the top collaborators of Lawrence David Scahill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence David Scahill. Lawrence David Scahill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Salpekar, Jay A. & Lawrence David Scahill. (2024). Psychopharmacology Management in Autism Spectrum Disorder. Pediatric Clinics of North America. 71(2). 283–299. 3 indexed citations
2.
Simonoff, Emily, Florence D. Mowlem, Oliver P. Pearson, et al.. (2022). Citalopram Did Not Significantly Improve Anxiety in Children with Autism Spectrum Disorder Undergoing Treatment for Core Symptoms: Secondary Analysis of a Trial to Reduce Repetitive Behaviors. Journal of Child and Adolescent Psychopharmacology. 32(4). 233–241. 6 indexed citations
3.
Murphy, Tanya K., Thomas Fernandez, Barbara J. Coffey, et al.. (2017). Extended-Release Guanfacine Does Not Show a Large Effect on Tic Severity in Children with Chronic Tic Disorders. Journal of Child and Adolescent Psychopharmacology. 27(9). 762–770. 48 indexed citations
4.
Sukhodolsky, Denis G., Douglas W. Woods, John Piacentini, et al.. (2017). Moderators and predictors of response to behavior therapy for tics in Tourette syndrome. Neurology. 88(11). 1029–1036. 75 indexed citations
5.
Snyder, Christopher S., Courtney McCracken, Christopher J. McDougle, et al.. (2016). No Apparent Cardiac Conduction Effects of Acute Treatment with Risperidone in Children with Autism Spectrum Disorder. Journal of Child and Adolescent Psychopharmacology. 26(10). 900–908. 10 indexed citations
6.
Hallett, Victoria, Luc Lecavalier, Denis G. Sukhodolsky, et al.. (2013). Exploring the Manifestations of Anxiety in Children with Autism Spectrum Disorders. Journal of Autism and Developmental Disorders. 43(10). 2341–2352. 134 indexed citations
7.
Tobiásová, Zuzana, Lawrence David Scahill, James F. Leckman, et al.. (2011). Risperidone-Related Improvement of Irritability in Children with Autism Is not Associated with Changes in Serum of Epidermal Growth Factor and Interleukin-13. Journal of Child and Adolescent Psychopharmacology. 21(6). 555–564. 24 indexed citations
8.
Hoekstra, Pieter J., Pieter W. Troost, Bertine Lahuis, et al.. (2010). Risperidone-Induced Weight Gain in Referred Children with Autism Spectrum Disorders Is Associated with a Common Polymorphism in the 5-Hydroxytryptamine 2C Receptor Gene. Journal of Child and Adolescent Psychopharmacology. 20(6). 473–477. 40 indexed citations
9.
Arnold, L. Eugene, Cristan Farmer, Helena C. Kraemer, et al.. (2010). Moderators, Mediators, and Other Predictors of Risperidone Response in Children with Autistic Disorder and Irritability. Journal of Child and Adolescent Psychopharmacology. 20(2). 83–93. 46 indexed citations
10.
McCracken, James T., Michael G. Aman, Christopher J. McDougle, et al.. (2010). Possible Influence of Variant of the P-Glycoprotein Gene ( MDR1/ABCB1 ) on Clinical Response to Guanfacine in Children with Pervasive Developmental Disorders and Hyperactivity. Journal of Child and Adolescent Psychopharmacology. 20(1). 1–5. 19 indexed citations
11.
Warnick, Erin M., V. Robin Weersing, Lawrence David Scahill, & Joseph Woolston. (2009). Selecting Measures for Use in Child Mental Health Services: A Scorecard Approach. Administration and Policy in Mental Health and Mental Health Services Research. 36(2). 112–122. 14 indexed citations
12.
Aman, Michael G., Jill A. Hollway, Christopher J. McDougle, et al.. (2008). Cognitive Effects of Risperidone in Children with Autism and Irritable Behavior. Journal of Child and Adolescent Psychopharmacology. 18(3). 227–236. 49 indexed citations
13.
Arnsten, Amy F.T., Lawrence David Scahill, & Robert L. Findling. (2007). Alpha-2 Adrenergic Receptor Agonists for the Treatment of Attention-Deficit/Hyperactivity Disorder: Emerging Concepts from New Data. Journal of Child and Adolescent Psychopharmacology. 17(4). 393–406. 113 indexed citations
14.
Scahill, Lawrence David, Michael G. Aman, Christopher J. McDougle, et al.. (2006). AProspective Open Trial of Guanfacine in Children with Pervasive Developmental Disorders. Journal of Child and Adolescent Psychopharmacology. 16(5). 589–598. 83 indexed citations
15.
Hamrin, Vanya & Lawrence David Scahill. (2005). SELECTIVE SEROTONIN REUPTAKE INHIBITORS FOR CHILDREN AND ADOLESCENTS WITH MAJOR DEPRESSION: CURRENT CONTROVERSIES AND RECOMMENDATIONS. Issues in Mental Health Nursing. 26(4). 433–450. 15 indexed citations
16.
Scahill, Lawrence David, Yukiko Kano, Robert A. King, et al.. (2003). Influence of Age and Tic Disorders on Obsessive-Compulsive Disorder in a Pediatric Sample. Journal of Child and Adolescent Psychopharmacology. 13(supplement 1). 7–17. 35 indexed citations
17.
Diler, Rasim Somer, et al.. (2003). Risperidone-Induced Obsessive-Compulsive Symptoms in Two Children. Journal of Child and Adolescent Psychopharmacology. 13(supplement 1). 89–92. 12 indexed citations
18.
Martin, Andrés, et al.. (2002). Datapoints: Use of Multiple Psychotropic Drugs by Medicaid-Insured and Privately Insured Children. Psychiatric Services. 53(12). 1508–1508. 21 indexed citations
19.
Scahill, Lawrence David, James T. McCracken, Christopher J. McDougle, et al.. (2001). Methodological Issues in Designing a Multisite Trial of Risperidone in Children and Adolescents with Autism. Journal of Child and Adolescent Psychopharmacology. 11(4). 377–388. 32 indexed citations
20.
Riddle, Mark A., Robert A. King, Maureen T. Hardin, et al.. (1990). Behavioral Side Effects of Fluoxetine in Children and Adolescents. Journal of Child and Adolescent Psychopharmacology. 1(3). 193–198. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James T. McCracken Breakdown of academic impact, for papers by Russell Schachar Breakdown of academic impact, for papers by Luís Augusto Rohde Breakdown of academic impact, for papers by Joel T. Nigg Breakdown of academic impact, for papers by Ellen Leibenluft Breakdown of academic impact, for papers by Christopher J. McDougle Breakdown of academic impact, for papers by Rosemary Tannock Breakdown of academic impact, for papers by Neal D. Ryan Breakdown of academic impact, for papers by Eric Mick Breakdown of academic impact, for papers by C. Keith Conners
Rankless by CCL
2026